Pregnant women should be receiving the antiviral drug Tamiflu at the first sign of symptoms of influenza, but many physicians are delaying treatment because of long-held prejudices about using any drugs during pregnancy, researchers from the Centers for Disease Control and Prevention reported this week in the medical journal Lancet.
Experts fear the same reluctance when the vaccine for the pandemic H1N1 influenza virus becomes available this fall. Historically, fewer than 15% of pregnant women are vaccinated for seasonal flu, despite the high risk of complications associated with infection. Read More…
